DSWL [DESWELL INDUSTRIES] 6-K/A: (Original Filing)
[EXPLANATORY NOTE DESWELL INDUSTRIES, INC. CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 As Previously]
DSWL [DESWELL INDUSTRIES] 6-K/A: EXPLANATORY NOTE DESWELL INDUSTRIES, INC. CONSOLIDATED STATEMENT OF
[EXPLANATORY NOTE DESWELL INDUSTRIES, INC. CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 As Previously]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]
BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER
[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]
ASX [ADVANCED SEMICONDUCTOR ENGINEERING] 6-K: (Original Filing)
[Note: X Yes Not applicable]
ASX [ADVANCED SEMICONDUCTOR ENGINEERING] 6-K: Note: X Yes Not applicable
[Note: X Yes Not applicable]
DSWL [DESWELL INDUSTRIES] 6-K/A: (Original Filing)
[EXPLANATORYNOTE DESWELLINDUSTRIES,INC.NSOLIDATEDSTATEMENTOFCASHFLOWS(UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 Previously Effect of Filed Changejustedsh flows from operating activities : Netome $ 1,499 $ 1,499 $ 1,195justments to reconcile netome to netsh provided by operating activities :]
DSWL [DESWELL INDUSTRIES] 6-K/A: EXPLANATORYNOTE DESWELLINDUSTRIES,INC.NSOLIDATEDSTATEMENTOFCASHFLOWS(UNAUDITED) ( U.S. dollars in thousands )
[EXPLANATORYNOTE DESWELLINDUSTRIES,INC.NSOLIDATEDSTATEMENTOFCASHFLOWS(UNAUDITED) ( U.S. dollars in thousands ) Year ended March 31 Year ended March 31, 2010 2010 2009 Previously Effect of Filed Changejustedsh flows from operating activities : Netome $ 1,499 $ 1,499 $ 1,195justments to reconcile netome to netsh provided by operating activities :]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]
BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG,
[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]
